Valuation (5%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -38.80 | -18.94 |
| PEG Ratio (TTM) | -7.22 | -5.61 |
| P/S Ratio (TTM) | N/A | 47.90 |
| P/B Ratio (TTM) | 18.82 | 30.89 |
| P/FCF Ratio (TTM) | -2.57 | -6.05 |
| Price to 5YR AVG Earnings Ratio | -4.28 | -5.69 |
| Price to 5YR AVG FCF Ratio | -5.85 | -13.62 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -47.14% | -17.89% |
| ROE (TTM) | -52.19% | 28.85% |
| Net Profit Margin (TTM) | N/A | -540.96% |
| ROIC 5YR AVG | -180.04% | -3.04% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -678.71% | -389.24% | -1,067.41% |
| Revenue | N/A | -33.33% | -20.00% |
| Net Income | -95.18% | -1,170.98% | -712.81% |
| Cash Flow | -33.28% | -457,930.23% | -274,796.14% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 24.24 | 5.75 |
| Quick Ratio (TTM) | 24.24 | 5.53 |
| D/E Ratio (TTM) | N/A | 1.08 |
| Interest Coverage (TTM) | N/A | -7.40 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 12.23 | 13.03 |
| LTL to 5YR AVG FCF | N/A | 0.08 |
| Shares Outstanding Growth 5YR AVG | 64.23% | 40.65% |